Safety and immune modulatory properties of etrasimod (APD334), a next-generation oral, selective sphingosine 1-phosphate receptor (S1PR) modulator, in healthy volunteers

Authors
Category Primary study
JournalJournal of Crohn's and Colitis
Year 2018
This article has no abstract
Epistemonikos ID: 7a378966b07ab3fbc4443ebbbaee2832864b1971
First added on: Feb 09, 2025